The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns and outcomes after metastatic recurrence following perioperative chemoimmunotherapy in triple-negative breast cancer (mTNBC).
 
Riccardo Asnaghi
No Relationships to Disclose
 
Carmine Valenza
No Relationships to Disclose
 
Nadia Bianco
No Relationships to Disclose
 
Monica Milano
Travel, Accommodations, Expenses - Gilead Sciences; Pfizer
 
Giacomo De Micheli
No Relationships to Disclose
 
Simona Manacorda
No Relationships to Disclose
 
Matteo Cavallone
No Relationships to Disclose
 
Dario Trapani
No Relationships to Disclose
 
Pier Paolo Maria Berton Giacchetti
No Relationships to Disclose
 
Claudia Sangalli
No Relationships to Disclose
 
Cristian Gialain
No Relationships to Disclose
 
Elisabetta Munzone
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Exact Sciences; Ipsen; Lilly; MSD Oncology; Pfizer; Pierre Fabre; Seagen
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Lilly; Novartis; Pfizer; Pierre Fabre; Roche
 
Marco Colleoni
No Relationships to Disclose
 
Giuseppe Curigliano
Leadership - ESMO; ESMO; ESMO Open; European Society of Breast Cancer Specialists (EUSOMA=
Honoraria - Ellipses Pharma
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celcuity; Daichi-Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; GlaxoSmithKline; Guardant Health; Hengrui Therapeutics; Lilly; Menarini; Merck; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen; Veracyte
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daichii Sankyo; Pfizer; Roche/Genentech